Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Voris

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Psychology|April 1, 1999
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilitiesJ C Voris
Psychiatric Services (Washington, D.C.)|February 25, 1999
Use of risperidone and olanzapine in outpatient clinics at six Veterans Affairs hospitalsJ C Voris, W M Glazer
Southern Medical Journal|November 1, 1991
Neuroleptic malignant syndrome associated with carbamazepineF M O'Griofa, J C Voris
QRB. Quality Review Bulletin|September 1, 1991
A postdischarge adverse drug reaction capture mechanism using medical record techniciansJ C Voris, M P Dunphy
The Journal of Clinical Psychiatry|April 1, 1982
Protocols for use of psychoactive drugs--Part IJ C Voris, G N Shaurette
American Journal of Hospital Pharmacy|January 1, 1983
Monitoring outpatients' plasma antidepressant-drug concentrations as a measure of complianceJ C Voris, C Morin, J S Kiel
Hospital Pharmacy|March 12, 1982
Tricyclic antidepressant education program and its evaluationJ C Voris, J E Wilson, J E DuBe
American Journal of Pharmaceutical Education|January 6, 1983
Physician and pharmacy student expectations of pharmacy practiceJ C Voris, R J Anderson, C L Kimberlin
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Development of Pseudomonas aeruginosa resistance to norfloxacin during therapyR C Rowen, T A Mullenix, J C Arroyo, et al.
Pharmacotherapy|April 17, 1998
Nefazodone: single versus twice daily doseJ C Voris, G N Shaurette, P S Sebastian, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychology|April 1, 1999
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilitiesJ C Voris
Psychiatric Services (Washington, D.C.)|February 25, 1999
Use of risperidone and olanzapine in outpatient clinics at six Veterans Affairs hospitalsJ C Voris, W M Glazer
Southern Medical Journal|November 1, 1991
Neuroleptic malignant syndrome associated with carbamazepineF M O'Griofa, J C Voris
QRB. Quality Review Bulletin|September 1, 1991
A postdischarge adverse drug reaction capture mechanism using medical record techniciansJ C Voris, M P Dunphy
The Journal of Clinical Psychiatry|April 1, 1982
Protocols for use of psychoactive drugs--Part IJ C Voris, G N Shaurette
American Journal of Hospital Pharmacy|January 1, 1983
Monitoring outpatients' plasma antidepressant-drug concentrations as a measure of complianceJ C Voris, C Morin, J S Kiel
Hospital Pharmacy|March 12, 1982
Tricyclic antidepressant education program and its evaluationJ C Voris, J E Wilson, J E DuBe
American Journal of Pharmaceutical Education|January 6, 1983
Physician and pharmacy student expectations of pharmacy practiceJ C Voris, R J Anderson, C L Kimberlin
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Development of Pseudomonas aeruginosa resistance to norfloxacin during therapyR C Rowen, T A Mullenix, J C Arroyo, et al.
Pharmacotherapy|April 17, 1998
Nefazodone: single versus twice daily doseJ C Voris, G N Shaurette, P S Sebastian, et al.
Pageof 2